The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.
Hims & Hers Health (HIMS) shares nosedive on news from the US Food and Drug Administration (FDA) that the shortage in ...
Stock indexes continued to bear the brunt of weak consumer sentiment as the trading week drew near a close Friday. The Dow Jones Industrial Average was hit hard as blue chip UnitedHealth fell amid a ...